It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013
The iShares Nasdaq Biotechnology Index ETF (IBB) is trouncing the S&P 500 through the first three weeks of the year.
IBB data by YCharts
It's hard to imagine, but biotech stocks are starting off 2014 stronger than they did in 2013.
Here's the same IBB vs. S&P 500 comparison as above, but looking at the first 20 calendar days of 2013:
IBB data by YCharts The top-performing biotech and drug stocks year to date, according to S&P CapitalIQ:
Intercept Pharma (ICPT - Get Report) +329%
Rexahn Pharma (RNN)+116%
Neurocine Biosciences (NBIX - Get Report) +110%
CorMedix (CRMD - Get Report) +98%
Cell Therapeutics (CTIC - Get Report) +91%